Healthcare Services

Drugs of abuse testing market overview (2026–2030) with industry insights

April 21, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Expansion In Market Value Is Forecasted For The Drugs of Abuse (DOA) Testing Market Between 2026 And 2030?

The drugs of abuse (DOA) testing market size has seen significant expansion in recent years. It is anticipated to increase from $7.97 billion in 2025 to $8.68 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.0%. The historical growth of this market can be attributed to elements like workplace safety regulations, the prevalence of substance abuse, the demand for criminal justice screening, the uptake of immunoassay testing, and the broadening of laboratory infrastructure.

The drugs of abuse (doa) testing market is projected to experience substantial expansion over the upcoming years. This market is forecast to reach $12.17 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.8%. Factors driving this growth during the projection period include the demand for remote workplace testing, increased use of oral fluid testing, integration of real-time data, expanded regulatory enforcement, and public health monitoring initiatives. Key trends anticipated during this forecast span encompass the increasing uptake of workplace drug screening, a surging need for swift point-of-care testing, the proliferation of multi-panel drug testing kits, greater reliance on laboratory confirmation testing, and the incorporation of digital reporting alongside data management solutions.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/drugs-of-abuse-doa-testing-global-market-report

What Primary Drivers Are Shaping The Drugs of Abuse (DOA) Testing Market?

The rising need for drug abuse treatment is anticipated to drive expansion in the drugs of abuse (DOA) testing market in the future. Drug or substance abuse signifies consuming a substance in amounts detrimental to an individual or others. Drug testing helps identify substances not naturally present within the human body. This procedure begins with an initial screening, succeeded by a confirmatory test to detect and verify the existence of one or more substances; consequently, the growing need for drug abuse treatment will fuel market expansion. As an illustration, the Government of the United Kingdom (GOV. UK), a UK-based government platform, stated in December 2023 that from April 2022 to March 2023, 290,635 adults utilized drug and alcohol services, representing a modest rise from 289,215 in the preceding year. Moreover, treatment admissions climbed to 137,749, when contrasted with 130,490 and 133,704 in the two years before. Consequently, the expanding requirement for drug abuse treatment is a key factor propelling the drugs of abuse (DOA) testing market.

Which Segment Classifications Are Used In The Drugs of Abuse (DOA) Testing Market Segment Analysis?

The drugs of abuse (doa) testing market covered in this report is segmented –

1) By Product And Service: Analyzers, Rapid Testing Devices, Consumables, Laboratory Services

2) By Sample Type: Urine, Hair, Oral Fluid, Breath

3) By Application: Pain Management, Criminal Justice, Workplace Screening

4) By End User: Hospitals, Diagnostic Laboratories, Forensic Laboratories, Other End Users

Subsegments:

1) By Analyzers: Immunoassay Analyzers, Chromatography-Based Analyzers, Mass Spectrometry Systems

2) By Rapid Testing Devices: Urine Test Kits, Saliva Test Kits, Hair Test Kits

3) By Consumables: Test Strips, Reagents, Sample Collection Devices

4) By Laboratory Services: Toxicology Testing, Confirmation Testing, Screening Services

What Trends Are Affecting The Growth Of The Drugs of Abuse (DOA) Testing Market?

Major companies in the drugs of abuse (DOA) testing market are concentrating on developing innovative products, such as software-as-a-service (SaaS) platforms, to enhance testing efficiency, improve data management, and strengthen their competitive position. A software-as-a-service (SaaS) platform refers to a cloud-based application hosted by an external provider and accessed via the internet, allowing users to streamline workflows, analyze complex datasets, and gain actionable insights without needing local software installation. For instance, in December 2023, Merck KGaA, a US-based science and technology company, launched Addison, an advanced drug discovery software platform that integrates computer-aided drug design, machine learning, and generative AI to accelerate drug development. This platform provides synthesis recommendations for virtual molecules, connects digital drug design with practical manufacturability, and uncovers hidden insights from large datasets, ultimately increasing the likelihood of delivering effective new therapies to patients.

Which Firms Are Contributing To The Drugs of Abuse (DOA) Testing Market Ecosystem?

Major companies operating in the drugs of abuse (doa) testing market are Siemens AG, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Laboratory Corporation of America Holdings, Quest Diagnostics Inc., bioMérieux Inc., Dragerwerk AG & Co. KGaA, Aegis Sciences Corporation, NMS Labs, Clinical Reference Laboratory Inc., Cordant Health Solutions, Millennium Health, ACM Global Laboratories, Psychemedics Corporation, Alfa Scientific Designs Inc., Alere Toxicology Services, Omega Laboratories Inc., BioTek Laboratories, Premier Biotech Inc., Dominion Diagnostics LLC, Randox Toxicology Ltd., Cansford Laboratories Ltd., United States Drug Testing Laboratories Inc., American Bio Medica Corporation, Confirm BioSciences, Immunalysis Corporation, Medtox Diagnostics Inc., Forensic Fluids Laboratories

Get The Full Drugs of Abuse (DOA) Testing Market Report:

https://www.thebusinessresearchcompany.com/report/drugs-of-abuse-doa-testing-global-market-report

Which Region Leads The Drugs of Abuse (DOA) Testing Market In Terms Of Market Share?

North America was the largest region in the drugs of abuse (DOA) testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global drugs of abuse (DOA) testing market report during the forecast period. The regions covered in the drugs of abuse (doa) testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Drugs of Abuse (DOA) Testing Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/drugs-of-abuse-doa-testing-global-market-report

Browse Through More Reports Similar to the Global Drugs of Abuse (DOA) Testing Market 2026, By The Business Research Company

Pharma Admet Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/pharma-admet-testing-global-market-report

Drug Screening Market Report 2026

https://www.thebusinessresearchcompany.com/report/drug-screening-global-market-report

Cannabis Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/cannabis-testing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795